Ashley Carina Casucci, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 234 Clark Street, Worcester, MA 01606 Phone: 508-791-4976 |
Megan Elizabeth Klein, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 281 Lincoln St, Worcester, MA 01605 Phone: 508-334-1000 Fax: 508-856-3460 |
Garie R Morgenstern Stein, M.S., C.C.C. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 15 Donna Rd, Worcester, MA 01609 Phone: 508-799-2009 |
Miss Allison Leigh Goff Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 484 Main St, Worcester, MA 01608 Phone: 508-757-2756 |
Jennifer Kerr, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 77 Commodore Rd, Worcester, MA 01602 Phone: 508-373-3273 |
Pamela Jean Campellone, MS CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 484 Main St, Easter Seals Massachusetts, Worcester, MA 01608 Phone: 800-244-2756 Fax: 508-831-9768 |
Andrea Lynn Quinn, MS CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 335 Chandler St, Worcester, MA 01602 Phone: 508-753-2967 |
Adelle Levert Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 484 Main St, Worcester, MA 01608 Phone: 800-244-2756 |
Mrs. Kristen Carter Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 548 Park Ave, Suit B, Worcester, MA 01603 Phone: 774-823-1500 |
Patricia Nelson, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 484 Main Street, Easter Seals Massachusetts, Worcester, MA 01608 Phone: 800-244-2756 |
Ms. Audrey Grant Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 55 Lake Ave N, Speech Language Pathology, Worcester, MA 01655 Phone: 508-334-8700 |
Susan M. Swanson, M.A. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 76 Circuit Ave N, Worcester, MA 01603 Phone: 508-755-2737 |
Sharon Morin Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 484 Main St, Worcester, MA 01608 Phone: 508-757-2756 |
Ms. Carole Jean Mccann-gaboury, C.C.C.-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6 Vermont Ave, Worcester, MA 01603 Phone: 508-752-5163 |
Mr. Dana Howard Smith, MS, CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 281 Lincoln St, Worcester, MA 01605 Phone: 508-334-1000 Fax: 508-856-3460 |
Mrs. Randi Lynn Stewart, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 135 Gold Star Blvd, Worcester, MA 01606 Phone: 508-852-0600 Fax: 508-853-1907 |
Abigail Potvin Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 135 Gold Star Blvd, Worcester, MA 01606 Phone: 844-543-8437 |
Sandra Buck, M.S. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 484 Main St, Easter Seals Massachusetts, Worcester, MA 01608 Phone: 800-244-2756 Fax: 508-831-9768 |
Carolann Olson, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 123 Summer St Ste 332, Worcester, MA 01608 Phone: 508-363-6205 |
Mrs. Jamie Lynn Mobed Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 484 Main St, Worcester, MA 01608 Phone: 508-757-2756 |
News Archive
Valeant Pharmaceuticals International, Inc. today announced that that its wholly owned subsidiary, Valeant Pharmaceuticals North America LLC, received notice that the U.S. Food and Drug Administration (FDA) has approved the New Drug Application (NDA) for Jublia® (efinaconazole 10% topical solution), the first topical triazole approved for the treatment of onychomycosis of the toenails.
Biogen Idec and Portola Pharmaceuticals, Inc. today announced that they have entered into an exclusive, worldwide collaboration and license agreement under which both companies will develop and commercialize highly selective, novel oral Syk inhibitors for the treatment of various autoimmune and inflammatory diseases, including rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE).
Researchers from Sorbonne Université have been reviewing papers exploring different anti-COVID-19 drugs.
New information about how and where the innate immune system fights off viral infections that enter through the skin could lead to better treatments for viruses like Zika, dengue and measles, according to Penn State College of Medicine researchers.
› Verified 1 days ago